Agostinucci et al.50 demonstrated that AAA treatment reduced hypertension in a transgenic mouse model overexpressing Cyp4a12. Similarly, Sedláková et al.51 showed that AAA effectively reversed malignant hypertension in the Cyp1a1-Ren-2 transgenic rat model. The gene discussed is CYP1A1; the disease is triple-A syndrome.